Close Menu

NEW YORK (GenomeWeb) – Twist Bioscience has filed with the US Securities and Exchange Commission for a proposed public offering of 3 million shares of its common stock, the firm said after the close of the market on Monday.

In addition, it will grant the underwriters a 30-day option to purchase an additional 450,000 shares of common stock at the public offering price. Twist has not yet priced the offering.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.